In brief

Unseen by the naked eye, microbes colonize every inch of our bodies. Fungi are among the most difficult to study of the human microbiome.

© Pixabay

Figuring out the fungi that live on and inside us

30 Aug 2019

Recent progress in our understanding of Malassezia fungi is helping to unlock the secrets of their role in human health and disease.

Although the microbiome has been linked to everything from diabetes to mental health, most studies to date have focused on bacteria, and to a lesser extent, viruses. Much less is known about the impact of fungi, an entire kingdom of life distinct from animals, plants and bacteria. In particular, scarce information is available about a group of fungi called Malassezia, although millions can be found on every human being.

“Fungi are much harder to study than bacteria for many reasons—they are fastidious in culture, slow growing, possess more complex biology and genetics, and so on. Hence, understanding of fungi has seriously lagged that of other microbial fields,” said Thomas Dawson, Senior Principal Investigator at the Skin Research Institute of Singapore (SRIS), adding that “Malassezia represent one of the most difficult fungi to study.”

While Malassezia colonize human skin with ease, it was difficult to culture these fungi in the lab until scientists discovered that they required lipid supplementation. Moreover, not just any lipid would do. “We found that Malassezia cannot utilize unsaturated fatty acids, as they lack the enzyme Δ-9 desaturase,” Dawson said.

On the skin, Malassezia take up saturated fatty acids and leave behind unsaturated fatty acids such as oleic and palmitoleic acid, which are irritating and likely cause seborrhoeic dermatitis. Indeed, numerous members of the Malassezia genus appear to be involved in various inflammatory conditions. “Most researchers see Malassezia globosa as a key player in dandruff and seborrhoeic dermatitis, and Malassezia sympodialis as a key factor in atopic eczema. Recent work has also implicated Malassezia restricta in Crohn’s disease and irritable bowel disease,” Dawson said.

Conditions caused by Malassezia are generally treated with broad-spectrum antifungal compounds, particularly azoles. However, the widespread use of azoles in both medical and agricultural applications also led to antifungal resistance and treatment failure.

In a bid to reduce reliance on azoles, researchers are now working on identifying more specific targets in Malassezia that would be less likely to induce broad-spectrum drug resistance. These targets include enzymes that Malassezia produce to obtain nutrients.

The complex biochemical and immune signaling between Malassezia and the human host also remains poorly understood. “Future research will involve examining this signaling in the hopes of identifying materials which can hijack the system and either decrease Malassezia numbers or instruct them to behave differently and promote health instead of disease,” Dawson said.

The A*STAR-affiliated researcher contributing to this research is from the Skin Research Institute of Singapore (SRIS).

Want to stay up to date with breakthroughs from A*STAR? Follow us on Twitter and LinkedIn!


Dawson, T.L. Jr. Malassezia: The Forbidden Kingdom Opens. Cell Host and Microbe 25: 345-347 (2019). | article

About the Researcher

View articles

Thomas Dawson

Deputy Executive Director

A*STAR Skin Research Labs (A*SRL)
Thomas Dawson earned his PhD in pharmacology from the University of North Carolina in 1994. He then joined the Duke University Medical Center from 1994-1996 as a Pediatric Clinical Medical Genetics Fellow. From 1998-2015 he worked in Procter & Gamble’s Beauty Technology Division, before joining A*STAR’s Institute of Medical Biology (IMB) to develop and lead translational programs in hair and scalp biology. In 2018, Dawson moved to the Skin Research Institute of Singapore (SRIS) and the A*STAR Skin Research Institute (A*SRL), where he is currently the Deputy Executive Director. Dawson has over 30 years of research experience in end-to-end drug discovery, 30 granted patents, multiple products in the market, and a unique background in skin, hair and microbiome research.

This article was made for A*STAR Research by Wildtype Media Group